IAEA COVID-19 project draws more than $28 million in funding
An initiative by the International Atomic Energy Agency to help nearly 120 countries contain the COVID-19 pandemic has received a financial boost from member states and Takeda Pharmaceutical Company Limited.
The IAEA announced on May 13 that Takeda, a biopharmaceutical company based in Tokyo, donated 500 million yen (about US$4.7 million). Two days earlier, the IAEA announced that pledges from more than 10 member nations totaled €22 million (about US$23.8 million).